Biomarker ID | 1651 |
PMID | 30962764 |
Year | 2019 |
Biomarker | NLR (neutrophil to lymphocyte ratio) |
Biomarker Basis | Ratio |
Biomolecule | Others |
Source | Blood |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | HR: 1.62 (95% CI: 1.29-2.04) |
Effect on Pathways | NA |
Experiment | Progression Free Survival Vs No Progression Free Survival |
Type of Biomarker | Prognostic |
Cohort | 32 studies were in included in this meta study. Including a total of 21949 patients. NLR information for Progression Free survival was available from 12 studies |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0 |
Method Used | Immunological Test for leukocyte count |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |